Insider · CIK 0001283972
VEITINGER KLAUS R DR
Reports to the SEC for 5 companies · NEW YORK, NY
Transactions
50
Companies
5
Filings
12
CIK
0001283972
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-10-07 | SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-10-07 | SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-10-07 | SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-10-07 | SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-06-03 | SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-06-11 | SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-06-06 | SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-06-15 | Tricida, Inc.Stock Option (right to buy)A Award | — |
| 2022-06-14 | SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-06-10 | Tricida, Inc.A Award | — |
| 2021-06-10 | Tricida, Inc.Stock Option (right to buy)A Award | — |
| 2021-06-08 | SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)A Award | — |
| 2020-08-10 | Tricida, Inc.G Gift | — |
| 2020-06-11 | Tricida, Inc.A Award | — |
| 2020-06-11 | Tricida, Inc.Stock Option (right to buy)A Award | — |
| 2020-06-09 | SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)A Award | — |
| 2019-11-01 | Tricida, Inc.M Exercise/Conversion | +$1,400 |
| 2019-11-01 | Tricida, Inc.S Sale | −$68K |
| 2019-11-01 | Tricida, Inc.S Sale | −$68K |
| 2019-11-01 | Tricida, Inc.S Sale | −$68K |
| 2019-11-01 | Tricida, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2019-10-25 | Tricida, Inc.M Exercise/Conversion | +$1,400 |
| 2019-10-25 | Tricida, Inc.S Sale | −$63.5K |
| 2019-10-25 | Tricida, Inc.S Sale | −$63.5K |
| 2019-10-25 | Tricida, Inc.S Sale | −$63.5K |
| 2019-10-25 | Tricida, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2019-09-26 | Tricida, Inc.M Exercise/Conversion | +$1,120 |
| 2019-09-26 | Tricida, Inc.S Sale | −$21.3K |
| 2019-09-26 | Tricida, Inc.S Sale | −$18.7K |
| 2019-09-26 | Tricida, Inc.S Sale | −$3,926.45 |
| 2019-09-26 | Tricida, Inc.S Sale | −$20.8K |
| 2019-09-26 | Tricida, Inc.S Sale | −$18.2K |
| 2019-09-26 | Tricida, Inc.S Sale | −$4,960.26 |
| 2019-09-26 | Tricida, Inc.S Sale | −$22.2K |
| 2019-09-26 | Tricida, Inc.S Sale | −$18.4K |
| 2019-09-26 | Tricida, Inc.S Sale | −$3,344.41 |
| 2019-09-26 | Tricida, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2019-08-26 | Tricida, Inc.M Exercise/Conversion | +$1,120 |
| 2019-08-26 | Tricida, Inc.S Sale | −$46.5K |
| 2019-08-26 | Tricida, Inc.S Sale | −$46.4K |
| 2019-08-26 | Tricida, Inc.S Sale | −$46.4K |
| 2019-08-26 | Tricida, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2019-07-25 | Tricida, Inc.M Exercise/Conversion | +$1,120 |
| 2019-07-25 | Tricida, Inc.S Sale | −$44.3K |
| 2019-07-25 | Tricida, Inc.S Sale | −$44.3K |
| 2019-07-25 | Tricida, Inc.S Sale | −$44.3K |
| 2019-07-25 | Tricida, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2019-07-05 | Tricida, Inc.M Exercise/Conversion | +$880 |
| 2019-07-05 | Tricida, Inc.S Sale | −$39.9K |
| 2019-07-05 | Tricida, Inc.S Sale | −$43.3K |
Recent filings
- 4VEITINGER KLAUS R DR0001193125-25-233537SEC(opens sec.gov)
- 4VEITINGER KLAUS R DR0000950170-25-082427SEC(opens sec.gov)
- 4VEITINGER KLAUS R DR0000950170-24-073122SEC(opens sec.gov)
- 4VEITINGER KLAUS R DR0000899243-23-014860SEC(opens sec.gov)
- 4VEITINGER KLAUS R DR0001595585-22-000053SEC(opens sec.gov)
- 4VEITINGER KLAUS R DR0000899243-22-022577SEC(opens sec.gov)
- 4VEITINGER KLAUS R DR0001595585-21-000078SEC(opens sec.gov)
- 4VEITINGER KLAUS R DR0000899243-21-022976SEC(opens sec.gov)
- 5VEITINGER KLAUS R DR0001595585-21-000038SEC(opens sec.gov)
- 4VEITINGER KLAUS R DR0001595585-20-000086SEC(opens sec.gov)
- 4VEITINGER KLAUS R DR0000899243-20-016166SEC(opens sec.gov)
- 4VEITINGER KLAUS R DR0001595585-19-000246SEC(opens sec.gov)
Companies
Address
C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES STREET
NEW YORK, NY, 10013